The Double Patenting Trap: How Pharma Brands Accidentally Invalidate Their Own Moats
Pharma loves moatsuntil the moat becomes a trap.
In patent law, double patenting is one of those quiet, technical hazards that can turn a carefully built intellectual-property strategy into an avoidable vulnerability. And the most frustrating part? It …
The Double Patenting Trap: How Pharma Brands Accidentally Invalidate Their Own Moats Read Post »
